Effect of Nalbuphine Versus Fentanyl on Hemdoynamic Effects of Laryngoscopy
COMPARISON OF HEMODYNAMIC EFFECTS OF NALBUPHINE VERSUS FENTANYL: A RANDOMIZED, DOUBLE-BLINDED INTERVENTIONAL STUDY IN PATIENTS ON CARDIOPULMONARY BYPASS AT RAWALPINDI INSTITUTE OF CARDIOLOGY, RAWALPINDI
Rawalpindi Institute of Cardiology
98 participants
Feb 21, 2026
INTERVENTIONAL
Conditions
Summary
Participants will undergo routine pre-operative evaluation. An intravenous line will be placed in the recovery area. On arrival in the operating room, standard monitoring (blood pressure, heart rate, oxygen saturation, ECG, breathing monitor, and temperature) will be applied. A central venous catheter and an arterial line will be inserted under local anesthesia using sterile technique. Before anesthesia induction, patients will receive premedication including midazolam and an opioid pain-relief injection given slowly through the vein. General anesthesia will then be induced with etomidate. After adequate sedation, a muscle relaxant (atracurium) will be administered, and the patient will be ventilated with 100% oxygen using a face mask. The breathing tube will then be inserted and correct placement confirmed. During surgery, anesthesia will be maintained with oxygen, sevoflurane gas, and a continuous atracurium infusion. Hemodynamic parameters such as heart rate and blood pressure will be monitored throughout the peri-intubation and intraoperative period.
Eligibility
Inclusion Criteria3
- Weighing 40-70kg
- ASA III of either sex
- Undergoing cardiac surgery with CPB
Exclusion Criteria1
- • History of Drug Allergy • Pre-existing Asthma • Renal or Hepatic dysfunction • Extreme obesity • Pregnant / lactating patients • Difficult intubation/prolonged intubation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
IV Nalbuphine at dose of 0.2 mg/kg will be given 5 minutes before induction of anesthesia
3 Microgram per kilogram body weight IV Fentanyl will be given 5 minutes before induction of anesthesia
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07435337